|3.01||-0.05 / -1.63%|
Data as of 4:00pm ET
|3.01||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +66.11% increase from the last price of 3.01.
The current consensus among 3 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.